COVID-19 among children and adolescents

Children and adolescents infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are usually asymptomatic or have mild coronavirus disease (COVID-19) with low rates of hospitalization and death. Multisystem inflammatory syndrome in children (MIS-C) is a rare and severe complication of SARS-CoV-2 infection. This paper reviews an excerpt of the literature on disease burden and complications following COVID-19 in children and adolescents aged 0-17 years, in addition to the effects and adverse drug reactions of BNT162b2 and mRNA-1273 vaccinations among children and adolescents aged 5-17 years.

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:184

Enthalten in:

Ugeskrift for laeger - 184(2022), 9 vom: 28. Feb.

Sprache:

Dänisch

Beteiligte Personen:

Schelde, Astrid Blicher [VerfasserIn]
Nielsen, Katrine Finderup [VerfasserIn]
Nygaard, Ulrikka [VerfasserIn]
von Linstow, Marie-Louise [VerfasserIn]
Espenhain, Laura [VerfasserIn]
Koch, Anders [VerfasserIn]

Themen:

BNT162 Vaccine
Journal Article
N38TVC63NU
Review

Anmerkungen:

Date Completed 09.03.2022

Date Revised 09.03.2022

published: Print

Citation Status MEDLINE

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM337752176